Cambridge Investment Research Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$190K Sell
21,865
-17,873
-45% -$155K ﹤0.01% 3357
2025
Q1
$316K Buy
39,738
+15,030
+61% +$120K ﹤0.01% 2824
2024
Q4
$225K Buy
24,708
+588
+2% +$5.36K ﹤0.01% 3096
2024
Q3
$221K Buy
24,120
+567
+2% +$5.2K ﹤0.01% 3069
2024
Q2
$230K Sell
23,553
-164
-0.7% -$1.6K ﹤0.01% 2921
2024
Q1
$358K Buy
23,717
+3,243
+16% +$49K ﹤0.01% 2565
2023
Q4
$441K Sell
20,474
-516
-2% -$11.1K ﹤0.01% 2290
2023
Q3
$390K Sell
20,990
-846
-4% -$15.7K ﹤0.01% 2288
2023
Q2
$553K Sell
21,836
-7,814
-26% -$198K ﹤0.01% 2049
2023
Q1
$768K Sell
29,650
-3,136
-10% -$81.2K ﹤0.01% 1756
2022
Q4
$775K Sell
32,786
-5,159
-14% -$122K ﹤0.01% 1687
2022
Q3
$962K Buy
37,945
+6,914
+22% +$175K 0.01% 1502
2022
Q2
$1.03M Buy
31,031
+6,242
+25% +$207K 0.01% 1466
2022
Q1
$1.79M Sell
24,789
-10,509
-30% -$758K 0.01% 1202
2021
Q4
$3.24M Sell
35,298
-6,377
-15% -$586K 0.01% 875
2021
Q3
$5.29M Sell
41,675
-4,947
-11% -$627K 0.03% 581
2021
Q2
$7.75M Sell
46,622
-1,738
-4% -$289K 0.04% 453
2021
Q1
$8.79M Sell
48,360
-9,085
-16% -$1.65M 0.05% 368
2020
Q4
$11.5M Buy
57,445
+18,641
+48% +$3.73M 0.07% 275
2020
Q3
$8.51M Buy
38,804
+23,948
+161% +$5.25M 0.06% 311
2020
Q2
$2.84M Sell
14,856
-17,848
-55% -$3.41M 0.02% 628
2020
Q1
$5.07M Buy
32,704
+22,501
+221% +$3.49M 0.05% 361
2019
Q4
$854K Buy
10,203
+2,381
+30% +$199K 0.01% 1247
2019
Q3
$530K Buy
7,822
+2,531
+48% +$171K ﹤0.01% 1461
2019
Q2
$351K Sell
5,291
-73
-1% -$4.84K ﹤0.01% 1655
2019
Q1
$298K Buy
5,364
+1,077
+25% +$59.8K ﹤0.01% 1810
2018
Q4
$213K Sell
4,287
-1,417
-25% -$70.4K ﹤0.01% 1877
2018
Q3
$493K Buy
5,704
+635
+13% +$54.9K ﹤0.01% 1454
2018
Q2
$294K Sell
5,069
-405
-7% -$23.5K ﹤0.01% 1747
2018
Q1
$221K Sell
5,474
-2,225
-29% -$89.8K ﹤0.01% 1903
2017
Q4
$268K Sell
7,699
-718
-9% -$25K ﹤0.01% 1731
2017
Q3
$279K Buy
+8,417
New +$279K ﹤0.01% 1597